Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
The clinical course of ANCA small-vessel vasculitis on chronic dialysis
Kidney International, 06/22/09
Lionaki S et al. - Infections were almost twice as frequent among patients with ESRD on maintenance immunosuppressants and were an important cause of death. Given the lower risk of relapse and higher risk of infection and death, it is suggested that immunosuppression be geared to patients with ESRD who present with active vasculitis.
Sofia Lionaki, 07/01/09
| Commentary Fear of disease relapse has lead physicians to continue maintenance immunosuppressive therapy in patients with ANCA vasculitis, including after end stage kidney disease (ESKD). In the absence of direct evidence that relapses are effectively prevented by continued immunosuppression, the possible benefit of such therapy must be weighed against the potential risks. Among patients with ESKD, our data reveal that the rate of disease relapse is significantly lower when compared to the same patients before ESKD and to patients with preserved renal function, while the risk of serious infections is elevated, especially among those on immunosuppressants. These findings suggest that the risks of maintenance immunosuppression may outweigh the potential benefit in this patient population, and its use should be reserved to patients with active vasculitis. |
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/20/09
Managing diabetes in hemodialysis patients: Observations and recommendations
Cleveland Clinic Journal of Medicine, 11/04/09
Vitamin D compounds for people with chronic kidney disease requiring dialysis
Cochrane Reviews, 10/19/09
Today in Vascular...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan
Modern Rheumatology, 10/14/09
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Circulation, 10/26/09
Pre-diabetes and arterial stiffness in uraemic patients
Nephrology Dialysis Transplantation, 10/30/09
Article Search
Sponsor


See Latest Articles


